𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carboplatin activity in untreated metastatic breast cancer patients — results of a phase II study

✍ Scribed by K. Kolarić; D. Vukas

Publisher
Springer
Year
1991
Tongue
English
Weight
388 KB
Volume
27
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of carboplatin and etopos
Phase II trial of carboplatin and etoposide in metastatic breast cancer
✍ John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg

Phase II study of ionidamine in patients
Phase II study of ionidamine in patients with metastatic breast cancer
✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi